Neutron beams for therapy always contain some ' Y ray contamination that varies with depth and with distance from the beam axis. The problem therefore arises how the varying ' Y ray contribution should be accounted for in dose specification. Not infrequently a "total effective dose" D E is quoted that is equal to the neutron dose plus the ' Y ray dose divided by a constant weight factor T. On general biophysical considerations this appears to be not a valid approach since it must be assumed that T decreases with increasing dose. The nature and the magnitude of this dose dependence is derived in the present article. Application of the results to actual doses per fraction and to factual ' Y ray to neutron ratios demonstrates that the dose dependence of T has, in fact, very minor influence on the numerical values of D E • Utilization of a constant value T is therefore satisfactory in practice.
INTRODUCTION
The specification of absorbed dose in a patient subjected to radiation therapy requires data on the spatial distribution of absorbed dose, but must also include information on radiation quality and its spatial variations. I A complete specification would have to be given in terms of the spectral distributions of fluence in particle type and particle energy in all points within the irradiated volume. For neutron beams this can be particularly important, as there may be substantial differences in radiation quality at different distances from the beam axis. 2 However, in practice, it will frequently be impossible to achieve a complete description and a simplified treatment is therefore not uncommon. In a first approximation the change of radiation quality can be characterized by the varying ratio of neutron to )'-ray dose, and quoting the two doses separately can therefore be a satisfactory procedure. Frequently one may wish to go even one step further and specify a neutron dose that is equivalent to the combination of the actual neutron and )'-ray doses. The problem then arises whether it is acceptable to use a constant weight factor for the )'-ray component or whether it is essential to applya variable factor that depends on the magnitude of the neutron and the )'-ray doses. This problem will be considered.
COMBINED EFFECT OF THE NEUTRON AND GAMMA DOSE
The need for the computation of an effective dose per fraction arises mainly in the consideration of effects on the normal tissue where tolerance levels are commonly related to a single quantity. An example of such a quantity is the nominal dose, computed by the Ellis-formula or its modification for neutron irradiation. 3 The derivation of this or similar quantities requires the statement of effective doses per fraction rat her than the separate specification of a neutron and a )'-ray dose. The following considerations will therefore refer to normal tissue rather than to the tumor. This simplifies the discussion because the complicating aspect of hypoxic cells and of reoxygenation need not be taken into account. Instead the analysis can be linked to a consideration of survival curves. Survival curves of mammalian cells can be represented by various equations. Among these the linear-quadratic equation for the logarithm of the survival S
is of the simplest form and it has the advantage that it permits a straightforward biophysical interpretation. 4 In this interpretation the linear term corresponds to a one-particle effect. The quadratic term (bD)2 corresponds to a two-particle effect. As the coefficients a and b depend, among other factors on radiation quality, one has different survival relations for neutrons and for )' rays:
The indices N and G refer to neutrons and to )' rays. According to the biophysical interpretation 4 the logarithmic reduction of cell survival probability, -ln S. is proportional to the yield of lesions. The linear terms in absorbed dose represent lesions that are formed in individual particle tracks. These linear terms are therefore simply additive for neutrons and )' rays. The quadratic terms represent the pairwise interaction of sublesions that are formed by separate particles; they are therefore proportional to the square of the yield of sublesions. It follows that the yield of sublesions is for ')' rays proportional to bcDc and for neutrons to bND N . Zaider and Rossi 5 give a more detailed discussion of this survival equation under a mixed irradiation. It should be pointed out that the linear-quadratic relation may be merely an approximation that is in reasonable agreement with experimental da ta without being rigorously valid. It can nevertheless be utilized, since the present analysis aims not at a precise formulation but at a rough assessment of the nature of the dose dependence for the weight factor 7.
DETERMINATION OF THE WEIGHT FACTOR
Equation ( aND N + a N Dc/7 + bfvDfv + 2bF.DNDC/7 + bfvDb!7 2 = aND N + acDc + bfvD;' + bbDb + 2bNbcDNDC (6) and: (7) therefore:
with: where D T is the total absorbed dose:
and p the relative')' ray contribution:
The formula for 7 appears somewhat complicated, but it is readily evaluated. It will be noted that at small doses the value 7 converges towards aN/aC. while for large doses it tends towards bN/b c . If the ')'-ray dose is small compared to the neutron dose (p « 1) one obtains the simpler relation:
NUMERICAL EVALUATION AND DISCUSSION
Ha1l 6 ,7 has recently performed extensive intercomparisons of survival curves of V -79 hamster cells exposed to neutron beams at various therapy installations. The experiments include also repeated control experiments with ')' rays.
The ')'-ray survival curves can be represented by the parameters ac = 0. The ratios aN/aC are therefore contained within a range of values from roughly 3-6, and the dependence of RBE on the total dose DT that corresponds to the values 3, 4, and 6 is plotted in Fig. 1 5, At doses DT of 1-2 Gy the graph for aN/aC = 4 agrees weil with the value of T = 3 that is presently used at most neutron therapy centers for d( 15) + Be neutrons. It provides therefore the dependence ofvalues T on total dose that can be compared to the use of a fixed value T.
Table 1 exemplifies the differences in numerical values for the effective dose D E that result from the use of fixed and variable values T. The ratios of the 'Y ray to neutron dose for two depths at the isocentric neutron therapy facility CIRCE in Essen (see Fig. 3 Gy-I that agrees with the ratio aN/aG = 4 (intermediate panel in Fig. 2) . The results are given in the penultimate row of boxes in Table 1 . At the bottom of Table 1 The essential result is that there is, indeed, a pronounced dependence of the weight factor T on total dose D T . This applies for both sets of parameters that are considered. However, neither the absolute uncertainty of T nor its dependence on D T have substantial influence on the magnitude of the resulting effective dose D E . The use of a fixed weight factor T is therefore still justified in clinical applications.
It remains to examine the possibility that the coefficient of the quadratic term in absorbed dose is larger for neutrons Medleal Physles, Vol. 7, No. 5, Sept.lOel. 1980 than for I' rays. For this purpose the weight factor T is derived für aN/aG = 4 as in Fig. 2, but with bN/b G = 2 . The results are given in Fig. 4 . As expected, the dependence of T on total dose is less pronounced in this case. This implies that the use of a constant weight factor T leads to even smaller imprecisions if b N exceeds b G .
CONCLUSION
In agreement with experimental observations and with general biophysical considerations, the RBE of neutrons relative to 1'. rays is largest at smallest doses. It follows that the factor T, that weights the neutron absorbed dose relative to the I' ray absorbed dose, decreases with increasing dose per fraction. From the linear-quadratic dependence of the logarithm of cellular survival and from parameters of survival curves, a numerical dependence of T on total dose can be obtained.
Although the dependence of T on dose is pronounced, it plays only a very minor role in actual numerical evaluations. It is consequently acceptable to apply a fixed weight factor T in order to correct for the 'Y-ray component in a neutron beam. In the present analysis parameters from cell survival curves are used as input data to obtain general guidance on the magnitude of the numerical values in the equations. However, it is evident that appropriate values of T must be based on radiobiological investigations and clinical trials with a particular neutron beam.
The general conclusion of this investigation will not be applicable to a mixed modality treatment where substantial I' ray and neutron doses are given in one session. Only in such cases would the dose dependence of T have to be taken into account.
